280 results on '"N. Morishita"'
Search Results
2. P-039 Male age is associated with sperm DNA integrity: Selection of high DNA integrity sperm by microfluidics sorting is critical to clinical outcomes in older patients
- Author
-
N Morishita, M Miura, Y Kobayashi, R Matsunaga, T Maeda, M Ochi, and T Horiuchi
- Subjects
Reproductive Medicine ,Rehabilitation ,Obstetrics and Gynecology - Abstract
Study question Does sperm DNA integrity affect clinical outcomes of ICSI? Summary answer Use of high DNA integrity sperm selected by microfluidics sperm sorting results in lower miscarriage rates in the patients of 39-years old and more. What is known already High sperm DNA damage is associated with decreased normal fertilization, embryo development and pregnancy rates, and an increased miscarriage rate. On the other hand, oocytes from older women have decreased pregnancy rate, and increased miscarriage rate because of possibility of low ability to repair sperm with DNA fragmentation, and dramatical increases of aneuploidy as women age. A microfluidic sperm selection chamber (MSS, ZyMōt™; DxNow) is a device designed to collect sperm with higher chromatin integrity than density gradient centrifugation (DGC). Study design, size, duration Sperm analysis was performed by sperm chromatin dispersion (SCD) test and comet assay in the same sample of 15 cases between October 2020 and February 2021. ICSI outcomes by DGC and MSS were compared with blastocyst development, and pregnancy rates in vitrified-thawed single blastocyst transfers cycle for 518 cases between August 2018 and May 2021. Participants/materials, setting, methods SCD test was optimized as a rapid procedure, with sperm showing a halo deemed normal, and those without a halo abnormal. Comet assay results were analyzed using CometScore 2.0, with comparison of %Tail DNA. ICSI outcomes were analyzed using multiple logistics regressions of male and female ages. Main results and the role of chance We found a positive correlation between male age and sperm DNA fragmentation rates in raw semen using SCD test (r = 0.70) and Comet assay (r = 0.42). Higher DNA integrity sperm could select using MSS than DGC. In this study with ICSI outcomes, 170 of 318 (53.5%) blastocyst transfers resulted in pregnancy, and 49 (28.8%) subsequently miscarried. The data were classified according to less than or more than 39 years old of male age detected by multiple logistics regressions. In patients with ≥39 years of male age, the female age was significantly higher and blastocyst and pregnancy rates were significantly lower, and the miscarriage rate was significantly higher than Limitations, reasons for caution The sample size for each study was small. Analysis of sperm DNA fragmentation and samples in ICSI outcomes were not the same. The retrospective nature of ICSI outcomes in this study does not allow controlling of unknown confounders. Wider implications of the findings Sperm DNA fragmentation depended on male age affected fertility outcomes. However, when male age is higher, masking the effect of male age by female age. In this study, we found out the improvement of ICSI outcome by using high DNA integrity sperm selected by MSS in both ≥39 years. Trial registration number Not applicable
- Published
- 2022
3. Microreview of Pityriasis versicolor and Malassezia species
- Author
-
N. Morishita and Yoshihiro Sei
- Subjects
Antifungal Agents ,Malassezia ,integumentary system ,Veterinary (miscellaneous) ,Fungus ,Pityriasis ,Biology ,biology.organism_classification ,medicine.disease ,Applied Microbiology and Biotechnology ,Microbiology ,Malassezia globosa ,Tinea Versicolor ,Botany ,Malassezia species ,medicine ,Humans ,Agronomy and Crop Science ,Mycelium - Abstract
Recently 11 Malassezia species were isolated. Attention has focused on the relationship between Malassezia species and Malassezia-related disease. The causal fungus of Pityriasis versicolor is M. globosa. The conditions of mycelial form induction are not clear for M. globosa.
- Published
- 2006
4. Temperature dependence of the transmission loss in KU-1 and KS-4V quartz glasses for the ITER diagnostic window
- Author
-
Takeo Nishitani, Tatsuo Sugie, N. Yokoo, and N. Morishita
- Subjects
Range (particle radiation) ,Tokamak ,Materials science ,business.industry ,Mechanical Engineering ,Transmission loss ,Window (geology) ,Fusion power ,law.invention ,Nuclear physics ,Nuclear Energy and Engineering ,Transmission (telecommunications) ,law ,Optoelectronics ,General Materials Science ,Irradiation ,business ,Quartz ,Civil and Structural Engineering - Abstract
Quartz glasses of KU-1 and KS-4V are candidate window materials for the ITER optical diagnostics in UV and visible range. The temperature dependence of the radiation-induced transmission losses in UV range has been investigated under γ-ray irradiation for the KU-1 and KS-4V quartz glasses up to 10 MGy. The KU-1 and KS-4V quartz glass samples were irradiated at room temperature, 100, 200 and 300 °C. Dose rate was 0.46–1.1 MGy, and 2.6 Gy/s from 1.1 to 10.4 MGy. It was confirmed that there is no significant loss in wavelength range longer than 350 nm for both window materials. Transmission loss in KU-1 is larger than that in KS-4V under temperature below 200 °C. KU-1 has large temperature dependence. On the other hand, temperature dependence is not clear in KS-4V above 100 °C. Prominent recover of the transmission loss was not observed after irradiation for each sample. From the transmission loss point of view, KS-4V is better window material than KU-1 at temperature below 200 °C. KU-1 is available at 300 °C.
- Published
- 2005
5. Effects of γ-ray and neutron irradiation on electrical characteristic of proton-conducting polymer electrolyte membranes
- Author
-
Bun Tsuchiya, Shinji Nagata, Kentaro Toh, N Morishita, Takashi Adachi, Michinori Yamauchi, N Nishitani, Naofumi Ohtsu, and T. Shikama
- Subjects
Conductive polymer ,Nuclear and High Energy Physics ,Materials science ,Radiochemistry ,Analytical chemistry ,Electrolyte ,Conductivity ,Radiation effect ,Membrane ,Nuclear Energy and Engineering ,Electrical resistivity and conductivity ,Absorbed dose ,General Materials Science ,Irradiation - Abstract
Radiation effects on proton-conducting polymer, perfluorosulfonic acid (PFSA) membranes were studied as the absorbed dose dependence of the electrical characteristics. V-I characteristic was measured under irradiation of y-rays and of 14 MeV neutrons. Under the neutron irradiation, the electrical conductivity of membranes decreased with an exponential form. In the case of the γ-ray irradiation, the electrical conductivity increased with increase of the dose and the membranes showed higher conductivity than before the irradiation, as much as 150 times after irradiation to a dose of more than 100 kGy. The effects on the electrical conductivity under irradiation is explained by structural changes in membranes caused by radiation effects as well as by changes at the interface between electrodes and membranes.
- Published
- 2004
6. ESR characterization of activation of implanted phosphorus ions in silicon carbide
- Author
-
Hisayoshi Itoh, N. Morishita, Akihiko Ohi, Takeshi Ohshima, and Junichi Isoya
- Subjects
Nuclear and High Energy Physics ,chemistry.chemical_compound ,Ion implantation ,Materials science ,chemistry ,Phosphorus concentration ,Annealing (metallurgy) ,Radiochemistry ,Silicon carbide ,Analytical chemistry ,Electron spin resonance spectra ,Instrumentation ,Ion - Abstract
Phosphorus ion implantations of 6H-SiC in the mean phosphorus concentration of the implanted layer of ∼1 × 10 18 cm −3 were performed both at multi-fold energy between 9 and 21 MeV and at 340 keV. In the high-energy implantations at room temperature, 400, 800 and 1200 °C and in the 340 keV implantations at 800 °C, electron spin resonance spectra arising from isolated shallow phosphorus donors have been observed after post-implantation annealing at 1650 °C, but were not observed in as-implanted state.
- Published
- 2003
7. Time-resolved Fourier-transform and continuous-wave ESR studies on photo-initiated polymerization
- Author
-
Yukio Mizuta, N. Morishita, and Keiji Kuwata
- Subjects
Radical ,Radical polymerization ,Diphenylphosphine oxide ,Photochemistry ,Atomic and Molecular Physics, and Optics ,law.invention ,chemistry.chemical_compound ,Monomer ,chemistry ,Polymerization ,law ,Vinyl acetate ,Electron paramagnetic resonance ,Isoprene - Abstract
Radical polymerization of vinyl monomers as initiated by the diphenylphosphinoyl (DPO) radical which is formed by the photo-cleavage of 2,4,6-trimethylbenzoyl diphenylphosphine oxide (TMDPO) was investigated by continuous-wave electron spin resonance (cw ESR) and Fourier-transform (FT) ESR. Well-resolved hyperfine structures (hfs’s) of the starting radicals were observed by the time-resolved cw ESR for vinyl acetate, ethyl vinyl ether, styrene, methyl methacrylate (MMA), and isoprene. The rates of formation and the spin-lattice relaxation were determined by time-resolved FT ESR for these starting radicals. In the polymerization of MMA and isoprene the primary propagating radicals were found for the first time by the observation of their well-resolved hfs’s with timeresolved cw ESR. On the basis of the kinetic analysis including the spin-lattice relaxation, the rates of formation and the spin-lattice relaxation were determined by simulation of the time profile of FT ESR for the primary propagating radicals of MMA and isoprene. The rate of the primary propagating step was found to be by two orders greater than an average value of whole propagating steps as obtained by a steady-state measurement.
- Published
- 2000
8. Annealing behaviours of defects in electron-irradiated diamond probed by positron annihilation
- Author
-
Satoshi Fujii, N Morishita, S. Shikata, K Mori, Shoichiro Tanigawa, Hisayoshi Itoh, and Akira Uedono
- Subjects
Annihilation ,Annealing (metallurgy) ,Chemistry ,Diamond ,Electron ,engineering.material ,Condensed Matter Physics ,Crystallographic defect ,Condensed Matter::Materials Science ,Positron ,Electron beam processing ,engineering ,Physics::Accelerator Physics ,General Materials Science ,Irradiation ,Atomic physics - Abstract
Annealing behaviours of defects in electron-irradiated diamond were studied using the positron annihilation technique. For a type IIa specimen after 3 MeV electron irradiation with a dose of 1 × 1018 cm-2, the major species of vacancy-type defects was determined to be neutral monovacancies, V0. The trapping rate of positrons by V0 decreased above 600 °C annealing, but the annihilation mode of positrons trapped by vacancy-type defects was observed even after 900 °C annealing. For a type Ib specimen after the irradiation, the major species of vacancy-type defects was determined to be negative monovacancies, and the formation of nitrogen-monovacancy pairs, N-V, was observed after 650 °C annealing. The annihilation probability between positrons and electrons with a broad momentum distribution was found to be increased by the trapping of positrons by N-V.
- Published
- 1999
9. Defects in synthesized and natural diamond probed by positron annihilation
- Author
-
N Morishita, Akira Uedono, S. Shikata, Hisayoshi Itoh, S. Tanigawa, and Satoshi Fujii
- Subjects
Physics ,Annihilation ,Astrophysics::High Energy Astrophysical Phenomena ,Diamond ,Trapping ,engineering.material ,Condensed Matter Physics ,Acceptor ,Positron ,Impurity ,Vacancy defect ,engineering ,Electron beam processing ,Physics::Accelerator Physics ,General Materials Science ,Atomic physics - Abstract
Defects in synthesized and natural diamond were studied using the positron annihilation technique. For a synthesized type IIa specimen, the lifetime of positrons annihilating from the free state was determined to be 98.7 ps. For a synthesized type Ib specimen, the effects of the annihilation of positrons trapped by open spaces introduced by substitutional nitrogen atoms on the positron parameters were discussed. After electron irradiation, the species of the major vacancy-type defects was identified to be a neutral and/or negatively charged monovacancy. For natural type IIa and IIb specimens, the annihilation mode of positrons trapped by vacancy clusters was observed. For the natural type IIb specimen, the temperature dependence of the trapping rate of the vacancy clusters was explained assuming that these clusters act as compensators for acceptor impurities (boron).
- Published
- 1999
10. Silicon vacancies in 3C-SiC observed by positron lifetime and electron spin resonance
- Author
-
Takeshi Ohshima, Hisayoshi Itoh, Hajime Okumura, N. Morishita, Isamu Nashiyama, Atsuo Kawasuso, Masahito Yoshikawa, Sohei Okada, and Sadafumi Yoshida
- Subjects
Materials science ,Silicon ,Condensed matter physics ,Annealing (metallurgy) ,chemistry.chemical_element ,General Chemistry ,Trapping ,Crystallographic defect ,law.invention ,Nuclear physics ,Positron ,chemistry ,law ,General Materials Science ,Electron paramagnetic resonance ,Positron annihilation - Abstract
2512 (1996)]. The trapping coefficient of single-negative silicon vacancies was also derived.
- Published
- 1998
11. Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirin
- Author
-
N. Harada, N. Hiramatsu, T. Oze, N. Morishita, R. Yamada, H. Hikita, M. Miyazaki, T. Yakushijin, T. Miyagi, Y. Yoshida, T. Tatsumi, T. Kanto, A. Kasahara, M. Oshita, E. Mita, H. Hagiwara, Y. Inui, K. Katayama, S. Tamura, H. Yoshihara, Y. Imai, A. Inoue, N. Hayashi, and T. Takehara
- Subjects
Adult ,Male ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Interferon alpha-2 ,Gastroenterology ,Antiviral Agents ,Polyethylene Glycols ,chemistry.chemical_compound ,Risk Factors ,Virology ,Internal medicine ,Ribavirin ,Medicine ,Humans ,Alanine aminotransferase ,Aged ,Retrospective Studies ,Hepatology ,business.industry ,Incidence ,Interferon-alpha ,Alanine Transaminase ,Hepatitis C ,Hepatitis C, Chronic ,Middle Aged ,medicine.disease ,Recombinant Proteins ,Infectious Diseases ,chemistry ,Hepatocellular carcinoma ,Female ,business - Abstract
Pegylated interferon (Peg-IFN) plus ribavirin combination therapy is effective in patients with hepatitis C virus (HCV) infection and normal alanine aminotransferase levels (NALT). However, it remains unclear whether the risk of hepatocellular carcinoma (HCC) incidence is actually reduced in virological responders. In this study, HCC incidence was examined for 809 patients with NALT (ALT ≤ 40 IU/mL) treated with Peg-IFN alpha-2b and ribavirin for a mean observation period of 36.2 ± 16.5 months. The risk factors for HCC incidence were analysed by Kaplan-Meier method and Cox proportional hazards model. On multivariate analysis among NALT patients, the risk of HCC incidence was significantly reduced in patients with sustained virological response (SVR) or relapse compared with those showing nonresponse (NR) (SVR vs NR, hazard ratio (HR): 0.16, P = 0.009, relapse vs NR, HR: 0.11, P = 0.037). Other risk factors were older age (≥65 years vs60 years, HR: 6.0, P = 0.032, 60-64 vs60 years, HR: 3.2, P = 0.212) and male gender (HR: 3.9, P = 0.031). Among 176 patients with PNALT (ALT ≤ 30 IU/mL), only one patient developed HCC and no significant risk factors associated with HCC development were found. In conclusion, antiviral therapy for NALT patients with HCV infection can lower the HCC incidence in responders, particularly for aged and male patients. The indication of antiviral therapy for PNALT (ALT ≤ 30 IU/mL) patients should be carefully determined.
- Published
- 2013
12. Zoledronate and Prolonged Oral Etoposide for Elderly Extensive-SCLC Patients with Poor Performance Status
- Author
-
Makoto Kobayashi, N Morishita, N Murata, Shinichi Hirose, Shinichi Morishita, and T Kitagawa
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,Internal medicine ,medicine ,Poor performance status ,business ,Oral etoposide - Published
- 2009
13. Association between high grade ventricular arrhythmia and extent of left ventricular hypertrophy in hypertrophic cardiomyopathy
- Author
-
X S, Cheng, S, Kusachi, N, Urabe, K, Nogami, M, Takemoto, N, Morishita, S, Haraoka, and T, Tsuji
- Subjects
Adult ,Aged, 80 and over ,Male ,Heart Ventricles ,Myocardium ,Arrhythmias, Cardiac ,Cardiomegaly ,Cardiomyopathy, Hypertrophic ,Middle Aged ,hypertrophic cardiomyopathy ,arrhythmia ,Electrocardiography, Ambulatory ,cardiovascular system ,Humans ,echocardiography ,Female ,Heart Atria ,cardiovascular diseases ,Holter ECG ,Aged - Abstract
The association between the extent of left ventricular (LV) hypertrophy and severity of ventricular or atrial arrhythmias are examined. Two-dimensional echocardiography and 24-h Holter electrocardiography monitoring were performed in 60 patients with hypertrophic cardiomyopathy (HCM). According to the distribution of the LV hypertrophy, the patients were divided into three groups: 1. Apical hypertrophy (APH), 2. Septal hypertrophy, and 3. Extensive hypertrophy. Ventricular arrhythmias were found in 82% of the patients and supraventricular arrhythmias were detected in 70% of the patients. Lown grade III and IV arrhythmias occurred significantly more frequently in patients with extensive than with septal hypertrophy. Lown grade III to IV arrhythmias did not occur in patients with APH. Present results show a significant association between the extent of LV hypertrophy and the severity of ventricular arrhythmias in HCM.
- Published
- 1991
14. Study on creep of PC beam damaged by ASR
- Author
-
H Asai, H Maeno, N Morishita, and Hikaru Nakamura
- Subjects
Materials science ,Creep ,business.industry ,Structural engineering ,Composite material ,business ,Beam (structure) - Published
- 2008
15. GAS EVOLUTION FROM INSULATING MATERIALS FOR SUPERCONDUCTING COIL OF ITER BY GAMMA RAY IRRADIATION AT LIQUID NITROGEN TEMPERATURE
- Author
-
A. Idesaki, N. Koizumi, M. Sugimoto, N. Morishita, T. Ohshima, K. Okuno, U. (Balu) Balachandran, Kathleen Amm, David Evans, Eric Gregory, Peter Lee, Mike Osofsky, Sastry Pamidi, Chan Park, Judy Wu, and Mike Sumption
- Subjects
Materials science ,Hydrogen ,Liquid helium ,Gas evolution reaction ,chemistry.chemical_element ,Epoxy ,Liquid nitrogen ,law.invention ,chemistry ,Cyanate ester ,law ,visual_art ,visual_art.visual_art_medium ,Irradiation ,Composite material ,Radiation resistance ,Nuclear chemistry - Abstract
A laminated material composed of glass cloth/polyimide film/epoxy resin will be used as an insulating material for superconducting coil of International Thermonuclear Experimental Reactor (ITER). In order to keep safe and stable operation of the superconducting coil system, it is indispensable to evaluate radiation resistance of the material, because the material is exposed to severe environments such as high radiation field and low temperature of 4 K. Especially, it is important to estimate the amount of gases evolved from the insulating material by irradiation, because the gases affect on the purifying system of liquid helium in the superconducting coil system. In this work, the gas evolution from the laminated material by gamma ray irradiation at liquid nitrogen temperature (77 K) was investigated, and the difference of gas evolution behavior due to difference of composition in the epoxy resin was discussed. It was found that the main gases evolved from the laminated material by the irradiation were hydrogen, carbon monoxide and carbon dioxide, and that the amount of gases evolved from the epoxy resin containing cyanate ester was about 60% less than that from the epoxy resin containing tetraglycidyl‐diaminophenylmethane (TGDDM).
- Published
- 2008
16. Transducer for multicolor distinction with ECB mode liquid crystal cell
- Author
-
Akihiro Kondo, N. Morishita, H. Kato, and Y. Inagaki
- Subjects
Materials science ,Birefringence ,business.industry ,Transductor ,Electronic, Optical and Magnetic Materials ,Photodiode ,law.invention ,Optics ,Transducer ,Filter (video) ,law ,Optoelectronics ,Electrical and Electronic Engineering ,Image sensor ,business ,Optical filter ,Voltage - Abstract
A small transducer for distinguishing color with high spectral selectivity is proposed. It consists of an Si p-n junction photodiode and a filter consisting of an electrically controlled birefringence (ECB) mode liquid-crystal cell mounted on the photodiode. Since the spectral transmittance of the filter can be electronically tuned by regulating the applied voltage across the liquid-crystal cell, a filter having continuously different spectral response with time can be realized. The filter can accurately distinguish colors by observing the photodiode output at increasing or decreasing voltage across the liquid-crystal cell. Eight kinds of colored paper are discerned by the transducer. >
- Published
- 1990
17. Formation of uniform titanium dioxide films by sputtering of tapered targets in an electron cyclotron resonance plasma
- Author
-
Shigeyuki Ishii, M. Sunagawa, Y. Koizumi, F. Tani, Yushi Kato, and N. Morishita
- Subjects
Materials science ,business.industry ,Plasma ,Sputter deposition ,Electron cyclotron resonance ,Physics::Plasma Physics ,Sputtering ,Magnet ,Optoelectronics ,Thin film ,business ,Instrumentation ,Microwave ,Slotted waveguide - Abstract
A rectilinearly wide plasma has been formed by electron cyclotron resonance (ECR). The ECR magnetic field is generated in the long range using a pair of 300-mm length magnets with oppositely facing poles. Microwave of 2.45-GHz frequency is supplied through a quartz window from a slotted waveguide placed between the magnets. A preliminary experiment is conducted to acquire basic data for sputtering targets to fabricate wide, uniform thin films. It is established by simulation that sputtering directivity obeys the square-root cosine law. Two planar titanium targets are lined up in parallel with the slotted waveguide. They are so tapered as to point their edges at each other and soaked in the uniform plasma. Uniform films are formed within an area of 180×180 mm2 in a 200-mm width plasma by sputtering the tapered targets and varying the direction of substrate surface to the targets.
- Published
- 1998
18. Evolved Gases from Organic Materials Used in the Superconducting Magnets Irradiated by Gamma Rays at Liquid Nitrogen Temperature
- Author
-
Hirokatsu Ohhata, Toru Ogitsu, H. Itoh, Akira Idesaki, T. Kamiya, Nobuhiro Kimura, Yasuhiro Makida, Tatsushi Nakamoto, Akira Yamamoto, and N. Morishita
- Subjects
Materials science ,Hydrogen ,chemistry ,Gas evolution reaction ,chemistry.chemical_element ,Superconducting magnet ,Irradiation ,Liquid nitrogen ,Composite material ,Radiation resistance ,Liquid hydrogen ,Helium - Abstract
Polyimide films and glass fiber reinforced plastics (GFRPs) are used as insulating and structural materials for superconducting magnets in a neutrino beam line of the Japan Proton Accelerator Research Complex (J‐PARC). It is indispensable to evaluate radiation resistance of these materials, because they are required to keep their electrical and mechanical properties in a high radiation field of 30 kGy/year at low temperature of 4 K. In this work, the gas evolution resulting from chemical reactions induced in the polyimide films and GFRPs by γ‐ray irradiation at 77 K was investigated. It was found that the main component of the evolved gas was hydrogen. The amount of hydrogen evolved from the superconducting magnet system used in the neutrino beam line was estimated to be 0.37 mol/year corresponding to 0.01 L/year as the volume of liquid hydrogen. It indicates that the hydrogen evolved from the organic materials will not influence the operation of the helium purifying system.
- Published
- 2006
19. Mechanical Properties of Organic Materials Used in Superconducting Magnets Irradiated by Gamma Rays at Liquid Nitrogen Temperature
- Author
-
Akira Idesaki, Hirokatsu Ohhata, T. Kamiya, Toru Ogitsu, H. Itoh, Nobuhiro Kimura, N. Morishita, Yasuhiro Makida, Tatsushi Nakamoto, and Akira Yamamoto
- Subjects
Tear resistance ,Materials science ,Flexural strength ,Ultimate tensile strength ,Gamma ray ,Irradiation ,Superconducting magnet ,Liquid nitrogen ,Composite material ,Radiation resistance - Abstract
Radiation resistance of organic materials used in superconducting magnets for a 50 GeV–750 kW proton beam line for the J‐PARC neutrino experiment was studied with respect to mechanical properties. Specimens cooled at a liquid nitrogen temperature of 77 K were irradiated by gamma rays from 60Co with the maximum dose beyond 10 MGy. The flexural strength of glass‐fiber reinforced plastics (GFRPs), the tear strength of polyimide films and the tensile lap‐shear strength of adhesive films were evaluated. It was verified that the organic materials used in the superconducting magnets have the sufficient radiation resistance, and the degradation of their mechanical properties after the 10 years operation was estimated to be negligible.
- Published
- 2006
20. Irradiation and ESR analysis temperature dependence of the gamma-ray response of alanine-polystyrene dosimeters
- Author
-
H. Itoh, S. Biramontri, N. Morishita, and T. Kojima
- Subjects
Range (particle radiation) ,Radiation ,Materials science ,Dosimeter ,Radiochemistry ,Analytical chemistry ,Gamma ray ,Atmospheric temperature range ,chemistry.chemical_compound ,chemistry ,Absorbed dose ,Polystyrene ,Irradiation ,Temperature coefficient - Abstract
Response characteristics of the alanine-polystyrene dosimeter were studied at an absorbed dose of 5 kGy over the low irradiation temperature range −196 ∼ 30°C, and the ESR analysis temperature range 0 ∼ 50°C in the dose range 0.1 ∼ 10 kGy. The irradiation temperature coefficient previously estimated for the temperature range from 0 ∼ 70°C (+0.24%/°C) was verified down to −15°C, although about 8% lower values were obtained at −78 and −196°C based on the correction using the above coefficient. ESR intensity decreases with temperature during ESR analysis following the function of the reciprocal of absolute temperature based on Boltzmann's constant. The average temperature coefficient for three different dose levels during ESR analysis of the alanine-polystyrene dosimeter is −0.25%/K in the temperature range 0 ∼ 50°C.
- Published
- 1996
21. Dual-Layer Phase Change Recording Media For System with NA of 0.65 and Light Incidence on 0.6-mm-thick Substrate
- Author
-
T. Tsukamoto, S. Ashida, T. Nakai, K. Yusu, K. Ichihara, N. Ohmachi, N. Morishita, and N. Nakamura
- Published
- 2003
22. Periodic Measurement of N-Telopeptides of Type I Collogen in Serum (SNTX) for Early Diagnosis of Bone Metastasis in Patients with Lung Cancer
- Author
-
H. Daga, M. Tamiya, S. Tokunaga, K. Taira, H. Okada, H. Suzuki, N. Okamoto, N. Morishita, T. Hirashima, and K. Takeda
- Subjects
Oncology ,Hematology - Published
- 2012
23. Formation of large-area TiO/sub 2/ thin-films in electron cyclotron resonance sheet plasma and their characterization
- Author
-
Shigeyuki Ishii, Y. Koizumi, F. Tani, N. Morishita, Yushi Kato, and M. Sunagawa
- Subjects
Anatase ,Optical coating ,Materials science ,business.industry ,Analytical chemistry ,Optoelectronics ,Plasma ,Thin film ,Sputter deposition ,business ,Refractive index ,Electron cyclotron resonance ,Diffractometer - Abstract
Uniform, large-area TiO/sub 2/ thin films are formed by reactive sputtering deposition in an electron cyclotron resonance (ECR) sheet plasma. The plasma source consists of a pair of long permanent magnets and a slot antenna. The antenna is set up between magnets whose N poles face each other. The generated plasma are uniform in one direction. To make the thin-films uniform in large area, two triangular targets are adopted and substrates are turned at two different angles with respect to the targets. The target form and substrate angle are determined by simulation and experiment. The thin-films are characterized with a profilometer and an X-ray diffractometer. The films of TiO/sub 2/, especially rutile having high refractive index, are useful for optical coating. The generated films are of anatase that has refractive index of 2.5. Crystallization is improved by controlling the electric potential of the substrates and by annealing as well.
- Published
- 2002
24. Extension of Surgical Indication for Gastric Cancer with Peritoneal Metastasis by Intraperitoneal Chemotherapy
- Author
-
F. Imamura, Daisuke Makiura, Y. Goda, Y. Hashiguchi, M. Mizuta, N. Sugimoto, S. Fujita, Shinya Ueda, S. Ozaki, M. Kawayama, M. Niimi, Kojiro Futagami, N. Matsubara, T. Tamaki, M. Fukushima, K. Hirokaga, Won Seog Kim, A. Koyama, K. Matsumoto, H. Kusumoto, Y. Yoshida, T. Sasatomi, H. Akamatsu, A. Ohtsu, I. Sasaki, X. Liu, T. Ura, Chandra P. Belani, H. Yamamoto, K. Watanabe, N. Hokamura, H. Fukushima, H. Nishizaki, K. Yonesaka, Noriaki Ohuchi, S. Takao, H.-J. Tsai, Dimitri Pchejetski, K. Sunami, H. Fujimoto, J. Zhang, H. Samura, Tomoko Oku, M. Mori, Eiji Oki, T. Yano, N. Yamamoto, J. Tsukada, Yasutaka Sukawa, Kazuyoshi Yanagihara, A. Goy, J. Inoue, Kazuto Nishio, Y-C Chang, L. Wang, N. Kotani, M. Inomata, T. Nishimura, C.-C. Lin, N. Aisu, R. Saura, M. Makino, Hideki Shimodaira, Y. Fujishima, Satoshi Watanabe, H. Tanaka, Akiko Hisamoto, Koichi Akashi, J. E. Jang, T. Nobuoka, Chihiro Makimura, Taichi Isobe, T. Takahashi, C. Morizane, S.-M. Chang, N. Takigawa, F. Lv, N. Katagami, A. Kumagai, Takahide Komori, Koichi Hirata, N. Okamoto, A. Makiyama, Y. Takahashi, Hideyuki Hayashi, S. Iwasa, J.-C. Lin, J. S. Kim, K. Eguchi, A. Yokoyama, H. Kunimoto, M. Inoue, L. Sauer, H. Ueno, M. Nakano, A.-H. Kwon, Kiyoshi Ando, H. Nishimura, M. Kaibori, S. Arita, K. Tauchi, Erina Hatashita, H. Yoshioka, Ikuo Sekine, S. Iida, S.-F. Lin, J. Cao, H. Horinouchi, S. Atagi, H. Harashima, Hironori Ishigami, H. Isobe, Yoshimitsu Kobayashi, Shinichi Nishina, M. Motonaga, Tokuzo Arao, M. Edagawa, Kazuo Shirouzu, Kei Kawana, A. Kitamura, Emiko Sakaida, T. Ozaki, H. Fukada, Hiromichi Ishiyama, A. Tsuya, Manabu Muto, K. Takizawa, Satoru Kitazono, H. Uemura, T. Nakagawa, S. Kondo, Naoto Takahashi, Hisato Kawakami, M. D. Galsky, Shigeki Ito, Yoshihiko Maehara, S. Negoro, H. Matsushita, M. Kashiwa-Motoyama, Yoshinori Imamura, Kunio Okamoto, T. Ecke, Miyako Takahashi, T. Matsuno, K. Itoh, K. Tanaka, Kazuo Tamura, Y. Suzuki, A. Iwashima, K. Katayama, Tsuyoshi Shirakawa, M. Ohtsu, Ryohei Sasaki, M. Hayashi, M. Egyed, M. Tateyama, M. Munakata, T. Nomizu, T. Muta, T. Terauchi, Shin Takahashi, Y. Kohjimoto, I. Kawase, L. Qiu, Nozomi Niitsu, Y. Nishida, Hironori Yamaguchi, T. Sawai, T. Nakajima, Takanori Ishida, Tatsuo Oyake, M. Nagase, T. Yoshinami, Y. Sakata, Chiaki Imai, M. Kitazono, W. K. Oh, H. Kataoka, Y. Kakechi, Y. Terasaki, T. Miyagishima, Akira Yamada, A. Ono, R. Konno, M. Higashiguchi, Y. Namba, Hiroshi Kagamu, Eiki Ichihara, H. Nakasa, T. Yagi, Y. Tamaki, T. Onoe, N. Sonoda, Kazuhiko Nakagawa, H. Yamana, M. Sasaki, Yoji Ishida, K. Kaira, S. Yokoyama, W. Li, M. Tanioka, Eishi Baba, Hitoshi Kusaba, H. Suzuki, Sung Yong Oh, N. M. Hahn, Tomoko Kataoka, M. Mikami, Chikatoshi Katada, Y. Narita, J. Leach, T. Uehara, K. Miura, S. Yamamoto, O. Kobayashi, Kentaro Yamanaka, Katsuyuki Kiura, S. Hua, H. Miyao, Y. Kodama, Isamu Okamoto, K. Mikami, T. Hirashima, E. Konno, Naoko Chayahara, Junta Tanaka, Chang Fang Chiu, Hironobu Minami, Tadashi Hasegawa, Atsuo Okamura, T. Okusaka, K.-I. Nishiyama, M. Satouchi, Y. Maekawa, T. Kato, Rei Ono, F. Hongo, Mamoru Watanabe, T. Miki, M. Ogura, Masato Komoda, S. Natsugoe, Yuichi Takiguchi, I. Iwanaga, Hiroshi Soeda, Y. Fujiwara, M. Endo, H. Yasui, S. Katano, Satoshi Yuki, K. Nagai, H. Tsukuda, Jun Koshio, I. Hara, J. Tomomatsu, M. Kudo, Kenichi Yoshimura, T. Esaki, Satoshi Morita, R. Udagawa, M. Nakamura, S. Miura, K. Iwata, W. Su, N. Nonomura, S. J. Kim, Y. Omori, T. Shukuya, S. Y. Hyun, H. Hara, Yasunori Emi, M. Nezu, S. Tanimura, Koji Wada, Y. H. Min, D. Y. Hwang, Yoshito Komatsu, S. Takaishi, Kazuhiko Kobayashi, Mayumi Ono, K. Sato, Yuka Kato, T. Mine, S. Egawa, J. Li, N. Matsumura, Y. Tsuji, Hiroyuki Hata, Hirohisa Yoshizawa, S. Sogabe, Y. Guo, D. Kuroda, Chih-Cheng Chen, T. Takano, X. Hong, Y. D. Kim, K. Oda, Shoji Tokunaga, Masahiro Nozawa, Takeshi Sugawara, T. Fukui, Y. Saito, T. Fukuda, Yasuhisa Shinomura, Y. Yamashita, T. Minami, H. Mukai, Y. Ito, Ayumu Hosokawa, Hiroshi Nakatsumi, Y. Ohoka, S. Matsuyama, H. Takase, T. Akimoto, M. Ishizaki, T. Nakamura, Masahiro Tabata, T. Shimada, K. Shitara, Kimiharu Uozumi, T. Shiroyama, A. Umeta, N. Akakura, T.-Y. Chen, Kiyoko Kuwata, S. Emoto, Y. Naito, O. Muto, Cheolwon Suh, H. Oda, S. Fujii, Kenichiro Kudo, H. Hino, N. Morishita, Hiromichi Matsuoka, Y. Adachi, K. Minato, W.-Y. Kao, K. Hatake, Kosuke Ichikawa, Wataru Okamoto, S. H. Yoon, N. Wada, K. Uchida, U. Fujii, Ih-Jen Su, E. Vandendries, H. Ootsuka, Mitsuaki Tatsumi, K. Hatanaka, K. Matsui, M. Saijo, Fumihiko Fujita, W.-L. Hwang, Y. Negoro, M. Asanabe, Aya Kita, Hideo Baba, H. C. Chung, H. Igaki, J. Hashimoto, Yohei Funakoshi, Ukihide Tateishi, Masanori Toyoda, T. Feldman, Y. Kimura, T. Kondo, Yoshito Akagi, T. Kojima, A. Bamias, D. Takahari, Katsuyuki Hotta, K. Tobinai, K. Yamazaki, A. Volkert, T. Miyake, Hiroharu Yamashita, H. Iishi, Kazunori Murai, Y. Hata, M. Ri, H. Tomioka, S. Kato, M. Fukuoka, Y. Nakamura, Naomi Kiyota, Yee Soo Chae, T. Kimura, N. Gondo, Hiroshi Saeki, G. Sonpavde, H. S. Eom, K. Tane, Yasuo Ohashi, Yasuyuki Kawamoto, T. Beppu, T. Naito, M. Iwasaku, T. Ueda, R. Nakatake, Y. Umeyama, Takayasu Kurata, H. Kenmotsu, Hironori Ashinuma, Y. Miura, Ken-ichi Nibu, Y. Ogata, Toshihiro Miyamoto, N. Uike, K. Muro, S. Goya, Yasushi Takamatsu, Ichiei Narita, Chikashi Ishioka, T. Sueta, Satoshi Takeuchi, M.-C. Chang, Y. Iwanami, Yasuo Hamamoto, H. Kashihara, Yoshikazu Kotani, H. Daiko, Y. Kakugawa, J.-W. Cheong, T. Oochi, Joji Kitayama, K. Matsuo, M. Tamiya, Tzeon Jye Chiou, T. Sugiura, K. Kato, S. Krege, Masatomo Otsuka, A. Kitao, Y. Tanaka, Toru Mukohara, Masataka Taguri, Y. Hattori, T. Harada, Y. Hasegawa, S. Hoshino, K. Yoneyama, M. Ikeda, Shingo Tamura, H. Murakami, M. Kitada, K. Yanase, K. Nosho, and C. S. Chim
- Subjects
medicine.medical_specialty ,Chemotherapy ,medicine.diagnostic_test ,Colorectal cancer ,business.industry ,medicine.medical_treatment ,Cancer ,Hematology ,medicine.disease ,Gastroenterology ,Chemotherapy regimen ,Surgery ,Metastasis ,Oncology ,Pancreatic fistula ,Internal medicine ,medicine ,Gastrectomy ,business ,Laparoscopy - Abstract
Background The prognosis of gastric cancer with peritoneal metastasis is extremely poor. Neither systemic chemotherapy nor surgery alone prolongs survival of patients significantly. Methods Patients diagnosed with advanced gastric cancer underwent staging laparoscopy and received chemotherapy when peritoneal dissemination and/or cancer cells on peritoneal cytology were confirmed. The chemotherapy regimen consisted of S-1, weekly intravenous and intraperitoneal paclitaxel, which was verified in our phase II trial (Ann Oncol 2009). S-1 was administered at 80 mg/m2/day for 14 consecutive days, followed by 7 days rest. Paclitaxel was administered intravenously at 50 mg/m2 and intraperitoneally at 20 mg/m2 on days 1 and 8. Clinical response of chemotherapy was assessed by computed tomography, gastroendoscopy, peritoneal cytology and second-look laparoscopy. Radical gastrectomy was carried out when macroscopic curative resection was made achievable by chemotherapy. Chemotherapy was restarted after operation as soon as possible. Overall survival, relapse free survival, morbidity and mortality of gastrectomy were evaluated. Results Out of 100 patients with peritoneal metastasis who received chemotherapy, 60 patients underwent gastrectomy after response to chemotherapy, including 54 with macroscopic metastasis and 6 with positive peritoneal cytology only. A median of three courses were administered preoperatively (range 1–16). Total or distal gastrectomy with lymphnode dissection was carried out in 54 or 6 patients, respectively. The median survival time was 34.5 months. The median relapse-free survival was 16.7 months. The first site of relapse was the peritoneum in 24 patients and the other organ site in 17 patients. Postoperative complications included anastomotic leakage and pancreatic fistula in two patients each, which were healed conservatively. There were no treatment-related deaths. Conclusions Gastrectomy combined with S-1, intravenous and intraperitoneal paclitaxel is safe and active for gastric cancer patients with peritoneal metastasis.
- Published
- 2012
25. SRPX2 is a Novel Chondroitin Sulfate Proteoglycan that is Overexpressed in Gastrointestinal Cancer
- Author
-
T. Hirashima, Y. Omuro, C. Kondo, T. Kanematsu, K. Muraki, Po-Chuan Wang, K. Ishiguro, Young-Ae Park, C.-Y. Lu, C.-C. Liao, H. Tei, H. Takeyama, M. Toishi, A. D. Abdullah, M. Terada, K. Yamamoto, N. Yamamoto, K. Fujii, M. Sugimoto, H. Kakizaki, K. Shinozaki, Y. Okada, Yoko Inaguma, S. Shimizu, Shigeki Ito, H. Y. Lim, N. Nogami, N. Awata, M. Nishioka, H. Ueoka, Tomoya Ishii, Y. Ahn, Kazumichi Kawakubo, Y. Aoyagi, C. Nishijima, R. Kameda, A. Okamoto, Y. Yamashita-Kashima, H. Suzuki, K. Yamao, A. Yonemori, H. Fukuda, H. Katayama, K. Honoki, T. Nomura, Y. Tono, T. Shimoyama, J. Nagano, H. Miyamoto, Y. Takeda, M. Fukutake, N. Katsumata, S. Fujita, K. Fujimoto-Ouchi, D. Tamura, H. Obaishi, S. Mitsunaga, J.-H. Baek, Yuichiro Tada, K. Uno, S. Oura, M. Nakamura, Y. Imanura, Atsushi Kumanogoh, M. Manabe, Kaoru Tanaka, T. Yokota, K. Saito, K. Tamura, Yukihiko Fujii, T. Lim, Toshihiko Tomita, C. Seki, Masafumi Taniwaki, Tomohide Sugiyama, N. Kunami, T. Yoshino, Y. Takeoka, T. Yoshikawa, Won-Suk Lee, M. Hattori, H. Yasui, T. Motoya, T. Nishizaki, N. Kouge, E. Sato, S.H. Park, J.H. Hong, N. Mori, M. Tajika, K. Yasuda, Mika Nakamae, Kazuya Fukuoka, T. Shimomura, A. Suzuki, M. Arima, Hideo Koh, S. Tokunaga, N. Miyamoto, Masao Nakata, T. Ueda, Hideharu Kimura, H. Nakano, Kimikazu Yakushijin, M. Hayashi, K. Ishitani, K. Yoshida, T. Takeuchi, Shohei Yokota, K. Hirano, N. Horikawa, S. Bandoh, G. Naka, Y. Seki, M. A. De Velasco, F. Tanikawa, S. Hirano, S. Ohkawa, S. Kadowaki, M. Sakurai, R. Kaji, J.-I. Lee, K. Kitahara, K. Nihei, T. Sumi, Meiki Fukuda, S. Park, K. Nosaka, T. Maeda, O. Morimura, G. Sano, H.-L. Wu, Haruhiko Hirata, Mizuki Aimoto, Y. Igeta, K. Itoh, Y. Ikari, Kentaro Iwanaga, K. Itatsu, Akira Ueda, C. Oabata, H. Fujiwara, T. W. Kim, K. Misu, H. Mikayama, K. Morise, K. Nagata, M. Sato, Takashi Kijima, Kazuo Kasahara, Takahiro Mori, N. Mizuno, Y. Fujitani, Abdul Aziz Baba, K. Takashima, Kazuhide Higuchi, J.-C. Jo, G. Tamaki, S. Magoshi, R. Watanabe, A. Abe, M. Iino, H. Goto, Junji Tsurutani, Y. Katashiba, K. Kato, K. Hosono, L. Y. Kwan, Y. Okabe, N. Takeuchi, Chih-Hsin Tang, I. Kawase, Takayuki Kii, D. Kishino, K. Matsuura, K. Isobe, K. Monden, H. Udagawa, K. Kim, M. Tada, Kazuyoshi Yanagihara, Cheryn Song, T. Terui, Yasuhito Fujisaka, I. Yamaguchi, Hirokazu Fukui, K. Naito, T. Suzumura, H. A. Jung, N. Ureshino, Wataru Okamoto, H. Miyawaki, N. Nakamura, T. Tsukazaki, K. Furuta, K. Matsuda, S. J. Lee, Y. Ishiura, J.-L. Lee, Y. Kato, Shinichiro Hayashi, Y. Horita, J. H. Kim, Y. Tsutsumi, M. Inaoki, K.-P. Kim, Y. Ishigatsubo, T. Mikawa, M. Yamane, A. Husin, Yasufumi Takeshita, S. Kobayashi, N. Kubo, N. Hosono, Yeong-Shiau Pu, M. Ando, Keita Kudo, Hitoshi Nishitani, M. Mori, H. Daga, T. Fukuda, A. Nakaya, N. Fuse, I. Miki, W. Yamamoto, M. Fukushima, T. Ikezoe, H. Ueno, J.-H. Ahn, T. Matsumoto, A. Kuwahara, T. Ogura, N. Hirai, S. Mizuta, A. Ochiai, N. Masumori, S. Kim, Y. Ohki, Yoshinori Imamura, T. Tamaki, K. Nishino, Y. Aoyama, T. Ogawa, T. Koyama, M. Morise, K. Kawada, T. Masaki, Keishi Yamashita, S. Yamamoto, K. Tanimoto, M. Hori, Atsuo Okamura, Masataka Ikeda, K. Oishi, H. Hashimoto, Y. Ohe, M. Yasui, Y. Akatsuka, F. Imamura, Y. Hirayama, Ho Young Kim, S. Kishi, M. Jung, Y. Inukai, K. Miwa, S.-H. Nam, T. Hishima, T. Okusaka, Y. Horiuchi, A. Ioka, W. Fukushima, M. Yamauchi, N. Hokamura, K. Hirata, Y. Katou, K. Tada, K. Suzuki, K. Teramoto, Syusai Yamada, M. Iikura, Takeo Shimasaki, Y. Inoue, K. Kawahara, T. Kitani, H. Sawai, T. Terashima, K. Honda, Hitomi Umeguchi, Masataka Okamoto, M. Kita, Y. Yatabe, Y.-M. Cho, Sojiro Kusumoto, K. Hokkoku, Takaaki Sasaki, Masayuki Hino, M. Omi, H. Tanaka, S. Kawazoe, M. Sakai, H. Tsuchihashi, Kazushi Endo, R. Mauchi, K. Ohashi, H. Takasaki, N. Naganobu, K. Aoe, S.Y. Oh, C. Honma, Takahiro Miyamoto, K. Yamazaki, M. Fujii, T. Fujisawa, S. Morikawa, T. Yamauchi, Masayoshi Kobune, K. Kuwano, T. Onikubo, M. Kuyama, M. Asayama, T. Kozuki, M. Kanie, Masahiko Shibuya, Y. Yamamoto, N. Morishita, Y. Yoshii, Toru Mukohara, K. Izumi, Y.S. Park, N.-R. Lee, Y. Horio, K. Nakamura, M. Matsuda, K. Sugino, S.H. Lee, S. Ueno, Tsutomu Sato, Y. Hasumi, H. Yamamoto, T. Karasuno, Yong Chan Ahn, M. Kitamura, Y. Namba, K. Karasawa, S. Hayasi, K. Hashimoto, Y. Ozaki, Takayuki Takahama, A. Todaka, M. Inoue, S. Boku, A. Ohtsu, Tadashi Matsunaga, K. Togitani, H.-H. Wu, Hirofumi Kogure, H. Kitamura, T. Matsuzaki, M. Gouchi, Hyun-Jin Kim, T. Shiroyama, K. Okada, Y. Terasaki, K. Park, H. Katou, N. Kobayashi, D. Mohri, Y. Hasegawa, T. Yoshimasu, Masahiro Tabata, S. Hijioka, Y.-Y. Chen, Shinji Nakao, M. Kodaira, Akihiko Gemma, T. Yoshida, Hiroya Takiuchi, Masaki Fujimura, A. Shimoda, Hiroyuki Isayama, K. Ohta, T.-L. Chen, T. Maruyama, K. Maruyama, K.-W. Lee, Takashi Hirose, Y. Fujita, H. Kato, Maya Watanabe, S. Iwasa, H. Okuyama, Cherry Wu, A. Hata, K. Myo, M. Takase, Y. Urasaki, K. Shingu, Shingo Nishikawa, M. Tsuzuki, I. Hoshi, T. Maruo, Hiroki Yoshita, Hirohisa Nakamae, Shigeru Hatabe, Hideko Ikeda, Hayato Koba, Y. Hata, S. Matsushima, M. Yunokawa, S. Tamaru, J. S. Ahn, T. Funakoshi, S.-J. Jang, S. Kageyama, K. Nakagawa, H. Nishimori, Eizaburo Sueoka, K. Hashidume, S. H. Hong, Atsushi Kawaguchi, Tomomi Nakamura, H. Kaneko, A. Seki, K.-L. Tan, T. Ichimura, Y. Matsuda, M. Nezu, M. Kudo, H. Fujii, K. Shibata, S. J. Sym, K. Takeuchi, Chiharu Tabata, M. Takeshita, Y. Ueda, A. Nakayama, N. Nishiyama, Sang We Kim, Y. S. Kim, H. Suzushima, S. Soma, K. Miura, H. Gonda, D. Gomi, A. Mogi, K. Ishizuka, T. Mizutani, Y. Yamada, A. Sato, G. Kaneko, T. Samejima, R. Shimabukuro, Masahide Fujita, K. Horie, R. Ohhashi, T. Wakasa, H. Nomura, K. Sato, T. Hamaguchi, S. Horiguchi, M. Ootsuka, S. Kawabata, Y. Okamoto, A. Yoshida, H. Takeda, M. Sugiyama, Y. S. Hong, Y. Yanagita, Yasushi Ichikawa, K. Tomii, T. Enokida, Tzyh-Chyuan Hour, Y. Takeyama, Y. Matsuura, Y. Kakehi, S. Kanazawa, S. Kimura, T. Yamada-Murano, D. Abe, Nagio Takigawa, T. Yana, A. Ogino, R. Sakai, S. Watanabe, K. A. Kwon, Y. Nakai, O. Watanabe, Naokatsu Nakada, Masanori Toyoda, H. Inomata, R. Sekine, J. S. Lee, T. Shukuya, O. Ishiko, Y. Ikeda, K. Nakase, S. Kuzu, H. Mukai, K. Ozaki, R. Koyama, Takashi Nakano, K. Hashizume, E. Noguchi, N. Hida, Y. Takamatsu, Tomoko Yamagishi, H. Agatsuma, S. Miyamoto, D.H. Lee, H. Kunimoto, H. Ogino, T. Miya, Naoki Sasahira, A. Yamane, T. Takami, N. Imai, Y. Fukui, Tae Min Kim, T. Kita, Jiro Watari, H. Kawabata, N. Motohashi, K. Aomatsu, T. Obayashi, H. Hayashi, S.-H. Li, S. Sakata, H. Okada, K. Masa, T. Iwata, H. Yoshida, Tokuzo Arao, R. Hassan, H. Imaoka, M. Kobayashi, H. Iwasaki, K. Nomura, H. Harada, T. Watanabe, K. Kaneko, H. Nakagawa, K. Sakamoto, A. Hiasa, Katsuyuki Hotta, Nobuhiko Emi, S. Maruyama, M. Yonemura, H. Tsurumi, Takuhiro Yamaguchi, M. Nagata, T. Nakai, Motoki Yoshida, S. Motomura, A. Sakai, H. Inoue, Toshimitsu Yamaoka, T. Morikita, S. Hirokawa, Hideaki Ijichi, Namiki Masayuki, Meiko Nishimura, Y. Ishii, A. Shimatani, Jong-Hyeok Kim, M. Ujihara, Yuko Kanbayashi, Y. Nakashima, T. Hosoda, K. Sanada, S. Kondo, Y. Honma, S. Sakamoto, H. Kubo, M. Kondo, F. Nomura, M. Hashizume, T. Shiraishi, B.-S. Kim, T. Kouno, T. Maki, H. Akaike, Z. Saito, Junya Fukuoka, T. Ohnishi, C. H. Maeng, M. Wada, Jong-Mu Sun, C. Morizane, Y. Matsumoto, K. Migita, Y. Okamura, Sun Young Rha, Hiroyoshi Ichihara, J. Kato, N. Yoshimura, W.-J. Wu, N. Wada, M. Yoshihara, K. Hamai, Kazuhiko Koike, Woo Kyun Bae, Y. Maeda, S. Mimura, Y. Sakai, H. Wakasugi, H. Nishimoto, M. Nagano, K. Taira, I. Park, T. Inokuma, Katsuhiko Shimizu, Y. Nakahara, S. Okamura, K. Ogawa, F. Saito, Y. Miura, Hyo Jin Lee, K. Fujita, K. Takagi, T. Shiina, Charny Park, Shin Kuwakado, N. Moto, Y.-C. Chiu, S. Saji, T. Araya, J. Takeshita, H. Iwase, Naoe Goto, H. Murakami, T. Hayashi, K. Otsuka, Rishu Takimoto, H. Nakahama, C.-C. Shih, Naoko Aragane, S. Hamauchi, H. K. Ahn, N. Tomita, N. Chyayahara, T. Hida, K. Watanabe, Y. Kokubo, N. Katusmata, L. K. Chi, M. Okumura, T. Kusakabe, S. Homma, H. Nakagomi, Hiroo Katsuya, D. B. Shin, Naoko Chayahara, F. Fukuta, Kazutoshi Shibuya, Ayumu Hosokawa, F. Ota, R. Yoshino, M. Goto, Y. Shibata, J. E. Kim, H. Watanabe, K. Mandai, T. Shimamura, S. Inoue, M. Fujimoto, S. Mitsuoka, Kunio Okamoto, M.-J. Kim, E. Chung, H. Moriwaki, Y. Misumi, S. Ogawa, K. C. Lee, J.-O. Lee, H. Hirosawa, Yoshiki Terada, A. Kinoshita, J. Hong, Y. J. Kim, A. Kido, M. Kijima, Y. Shiota, H. Hayase, A. Sekikawa, M. Ahn, K. Komuta, M. Sasaki, T. Murakami, M. Okuda, N. Matsubara, R. Saitou, R. Nakamura, K. Masuo, Kazuko Matsumoto, K. Mouri, Y. Ookuma, Kazutoshi Komiya, K. Sakai, N. Yogo, Takahiko Nakane, M. Mukai, Isao Tachibana, Shiro Kimbara, Kentaro Okuda, T. Fujisaki, S.-J. Chuang, Y. Niwa, H. Oda, Y. Nishida, T. Ando, Yuichi Ando, J. Tong, C. Shimizu, J. Choi, Satoshi Iyama, H. Imai, K. H. Park, T. Misao, Yohei Funakoshi, Chang-Sik Yu, Tadashi Kimura, J. Hori, M. Itoh, S. Ebihara, S.-H. Gan, T. Yano, H. Okamoto, E. Fukutani, U. Tateishi, T. Ishihara, Takuro Yoshimura, T. Shinkai, A. Yokoyama, T. Kikuchi, Y. Yamashita, K. Hagiwara, Y. Noda, Y. Oyama, K. Okuno, Naomi Kiyota, K. Yonemori, K. Kuramoto, T. Shimoi, H. Hong, Ryuya Yamanaka, E. Matsuki, O. Kondo, H. Gondou, Yusuke Nakamura, M.-J. Ahn, Yoshiki Hayashi, Shiro Koh, S. Kosaka, Masahiro Gotoh, S. Mizuno, H. Nakamura, S. Okazaki, E. Ichiki, M. Ishizu, K. Ishikawa, Hiroyasu Kaneda, R. Yamamura, Tomonobu Koizumi, R. Ankathil, T. Takahashi, S. Nakatsuka, A. Kamuro, M. Ueno, T. Eguchi, S. Hirai, G. Saito, S. Kudoh, Masanao Nakashima, N. Okamoto, K. Akiyoshi, Hironobu Minami, K. Kubota, K. Okafuji, M. Aoe, T. Ito, K. Nishimura, S. Ota, C. Wong, A. Ooki, Takao Shirai, Wen-Yi Chou, M. Tamiya, H. Tabuse, Y. Kaneko, Y. Shimizu, Y. Murata, A. Okada, S. Sasada, Y. Takagi, A. Naitou, N. Katayama, Kaori Ito, T. Araki, Y. Fujiwara, H. Yokota, Shinya Kajiura, M. Imano, T. Iwai, T. Kobayashi, T. Kubota, N. Kanaji, M. Ohdate, T. Tsukamoto, S. Zenda, A. Fukutomi, T. Kumura, R. Ogawa, K. Shintaku, Kazuto Nishio, T. Morimoto, W. Shioyama, E. K. Cho, H.-I. Lu, Y. Suginoshita, K. Yamaguchi, Y. Shindo, N. Hirokami, J. Shimizu, Chihiro Makimura, K. Araki, T. Taniyama, T. Tanaka, Y. Tanbo, Hiroto Miwa, Y. Hirai, J. Park, Asao Hirose, M. Doi, A. Goto, S. Nomura, S. Ikegaya, A. Yoshii, M. Akahane, T. Kakuma, K. Miyabayashi, S. Y. Kim, H. Kitade, B. Han, K. Yamada, Tadayuki Oshima, J. Ishizawa, M. Miyata, E. Sasak, R. Aibara, N. Takahara, S. Kanno, T. Kojima, I. Ohno, E. Sasaki, E. Tone, A. Morita, R. Suzuki, Yukio Hosomi, Hiroo Ishida, T. Akimoto, N. Hashimoto, T. Takakuwa, K. Umekawa, A. Toyoshima, K. Hara, J. Kitagawa, H. Taniguchi, T. Kamiya, M. Takai, Y. Watanabe, Yasuhito Tanaka, A. Sawada, T. Yasui, Y. Onozawa, Akihiro Hirakawa, S. Okamoto, K. K. Kim, Y.-M. Wang, Y. Takai, T. Tsumura, H. Hirama, Shigeo Horiike, K. Kawasumi, N. Shimeno, Junya Kuroda, C.-Y. Huang, Y.-H. Chen, H. Ogata, S. Matsumoto, I. Takahashi, Hideo Tomioka, I. Okamoto, Itaru Endo, T. M. S. Kam, K. Sekihara, C.-T. Liu, K. Chikamori, N. Hirota, K. Hiramatsu, D. Hamaguchi, T. Nishii, N. Ohmiya, T. Shimizu, T. Sakaizawa, Hiromichi Matsuoka, K. Kawa, J. H. Ji, S. Izumi, T. Hara, Y. Tsuyumu, T. Oguri, T. Akiyama, Y. Ichida, A. Simoyama, T. Hirakata, Y. Yoshimitsu, Y. Sasaki, T. Yamazaki, T. Tsushima, R. Okamoto, Y. Tsukioka, Nobuhiko Seki, S.-M. Bang, Y. Kubota, N. Harada, C.-H. Huang, J. Y. Hong, T. Andou, T. Shimada, T. Doi, Yoshihiro Ono, S. Nanjo, H. Hara, Y. Kikukawa, M. K. Choi, K.-M. Rau, Y. Tomizawa, O. Maeda, K. Ishida, Y. Naito, N. Machida, T. Otsuka, T. Hase, H. Morishita, K. Fukuhara, M. Yoshino, M. Takahashi, H. Takahashi, Heui June Ahn, M. Nisimoto, Y. Sunakawa, Y. Miyakawa, Choung Soo Kim, S.-W. Wang, Takashi Sone, M. Iguchi, T. Shimokawa, Tomoyuki Nagai, K. Morioka, A. Numata, R. Toyozawa, R. Miyahara, Y. M. Ahn, Hyo Song Kim, D. W. Hwang, H. Takamori, Shin-Hee Lee, Narikazu Boku, T. Mizuno, N. Katakami, J. H. Lee, Y. Okuma, Koji Kurokawa, K. Takeda, N. Sakiyama, R. Tachikawa, Satoshi Morita, T. K. Fai, K. H. Seong, K. Yorozu, T. Okamura, Ryo Takahashi, T. Kotake, Y. Arai, T. Kawamura, K. Yakushijinn, Y. Shimada, H. Sugiyama, S. Kamachi, A. Mugitani, T. Yasue, Y. Sugihara, S. Shu, Y. Osaki, Kazuhisa Takahashi, Y. Hashiguchi, K. Funasaka, Y. S. Koo, Tohru Ohmori, S. J. Koh, N. Kanemura, H. Kotani, M. Hsin, T. Kagoo, and A. Inoue
- Subjects
biology ,Molecular mass ,business.industry ,Angiogenesis ,Hematology ,Cell biology ,chemistry.chemical_compound ,Oncology ,chemistry ,Proteoglycan ,Chondroitin sulfate proteoglycan ,Cancer cell ,medicine ,biology.protein ,Hepatocyte growth factor ,Antibody ,Cell adhesion ,business ,medicine.drug - Abstract
SRPX2 (Sushi repeat-containing protein, X-linked 2) has recently emerged as a multifunctional protein that is involved in seizure disorders, angiogenesis and cellular adhesion. Here, we analyzed this protein biochemically. SRPX2 protein was secreted with a highly post-translational modification. Chondroitinase ABC treatment completely decreased the molecular mass of purified SRPX2 protein to its predicted size, whereas heparitinase, keratanase and hyaluroinidase did not. Secreted SRPX2 protein was also detected using an anti-chondroitin sulfate antibody. These results indicate that SRPX2 is a novel chondroitin sulfate proteoglycan (CSPG). Furthermore, a binding assay revealed that hepatocyte growth factor dose-dependently binds to SRPX2 protein, and a ligand–glycosaminoglycans interaction was speculated to be likely in proteoglycans. Regarding its molecular architecture, SRPX2 has sushi repeat modules similar to four other CSPGs/lecticans; however, the molecular architecture of SRPX2 seems to be quite different from that of the lecticans. Taken together, we found that SRPX2 is a novel CSPG that is overexpressed in gastrointestinal cancer cells. Our findings provide key glycobiological insight into SRPX2 in cancer cells and demonstrate that SRPX2 is a new member of the cancer-related proteoglycan family.
- Published
- 2012
26. A Phase I Dose-Escalation Study of emd 1214063, an Oral Selective CMET Inhibitor, in Patients with Advanced Solid Tumors
- Author
-
M. Boyer, Masahiro Tsuboi, M. Laniado, T. Nukiwa, Kazuhiko Nakagawa, Hirohisa Yoshizawa, S. Kobayashi, Filip Janku, M. Takeda, Manfred B. Klevesath, Jun Sakakibara-Konishi, W. Uhl, K. Arakawa, Akihiko Gemma, N. Omachi, T. Tsuji, A. Tamiya, T. Yoshino, Yoshiki Ishii, N. Yamamoto, G. Falchook, T. Kawaguchi, Satoshi Oizumi, Luis Paz-Ares, Gerald S. Falchook, Andreas Johne, Y-L. Wu, J-C. Soria, Isamu Okamoto, P. Rougier, S. Atagi, A. Campbell, H. Lannert, Razelle Kurzrock, T. Shiroyama, Siquing Fu, K. Asami, H. Isobe, A. Ohtsu, V. Antic, S.-Y. Lee, K. Park, H. Crane, C.-M. Tsai, Sojiro Morita, Ralph Zinner, Jennifer J. Wheler, M. Wirth, Stephen P. Letrent, Sarina Anne Piha-Paul, Pasi A. Jänne, N. Yoshizuka, M. Tamiya, Tony Mok, K. Takeda, Motoki Yoshida, M. D. Rutstein, J.J. Wheler, H. Suzuki, Thierry Gil, H. Tada, S. Ballal, A. Grothey, S. Zastrow, N. Okamoto, Akira Inoue, Y. Ichinose, K. Sugio, S. Minomo, Aung Naing, Ian Taylor, S. Nakamura, Yoichi Nakanishi, Joe O'Connell, Y. Saijyo, J. T.abernero, Jane Q. Liang, F. Nasroulah, Suresh S. Ramalingam, K. O'Byrne, T. Mitsudomi, Axel Heidenreich, N. Morishita, V. Jego, K. Okishio, K. Yamazaki, Jürgen E. Gschwend, T. Hirashima, David S. Hong, M. Zühlsdorf, T. Yamanaka, D.S. Hong, X. Zhang, Apostolia-Maria Tsimberidou, J. Gerloff, A. Miao, Koichi Hagiwara, Kazuhiko Kobayashi, and Hesham M. Amin
- Subjects
medicine.medical_specialty ,business.industry ,Nausea ,Cmax ,Hematology ,Neutropenia ,medicine.disease ,Asymptomatic ,Gastroenterology ,Regimen ,Oncology ,Pharmacokinetics ,Pharmacodynamics ,Internal medicine ,medicine ,Carcinoma ,medicine.symptom ,business - Abstract
Background The cell surface receptor tyrosine kinase c-Met and its ligand, the hepatocyte growth factor (HGF), are implicated in tumor cell migration, invasion, survival and proliferation. EMD 1214063 is a novel potent and highly selective reversible, ATP-competitive small molecule c-Met inhibitor. Methods This is a phase I, first in human (FIH) clinical trial with escalating doses of EMD 121406(NCT 01014936). The primary objective is to determine the MTD. Secondary objectives include evaluation of safety, pharmacokinetics, anti-tumor effect and pharmacodynamics (Pd). Eligible patients had advanced solid tumors not amenable to standard therapies. Following a classical 3 + 3 dose escalation scheme, successive cohorts of patients were treated with once daily oral EMD 1214063 according to two 21-day-cycle schedules, either days 1-14 followed by a 7-day rest(regimen 1, R1), or continuous three times weekly administration (regimen 2, R2). Pd markers were evaluated in paired tumor biopsies. Results As of 30 March 2011, a total of 41 patients had been enrolled, 21 in R1 and 20 in R2. The dose was escalated from 30 mg/day to 115 mg/day in R2 and to 230 mg/day in R1. One DLT was reported in R1 at 115 mg/day, an asymptomatic, grade 4 lipase and G3 amylase elevation. No other DLTs or treatment-related SAEs were observed. The remaining treatment-related AEs of grade 2 or higher included nausea (n = 1), vomiting (n = 1), anorexia (n = 1), diarrhea (n = 1), and fatigue (n = 1) in R1, and neutropenia (n = 1) in R2. 37 patients (90%) had no drug-related toxicity greater than grade 1. At the dose levels investigated, median Cmax and AUC values increased with dose. Immunohistochemical analysis of a patient with pre- and on-treatment biopsies showed a decrease in phospho-c-Met staining intensity under treatment. Preliminary anti-tumor activity has been observed, including an unconfirmed PR in one patient and stable disease lasting for at least 4 months in 5 patients. One patient with sarcomatoid bladder carcinoma and multiple MET copies due to polysomy of chromosome 7 achieved SD for 16+ months. Conclusions The MTD has not yet been reached and dose escalation of EMD 1214063 continues. Updated results of this FIH study will be presented.
- Published
- 2012
27. The Clinical Significance of the Serum Cross-Linked N-Telopeptide of Type I Collagen as a Prognostic Marker for Non-Small-Cell Lung Cancer
- Author
-
T. Shiroyama, M. Tamiya, T. Hirashima, S. Morita, O. Morimura, K. Okafuji, N. Morishita, H. Suzuki, N. Okamoto, M. Kobayashi, and I. Kawase
- Subjects
medicine.medical_specialty ,Performance status ,business.industry ,Hazard ratio ,Cancer ,Hematology ,medicine.disease ,Gastroenterology ,Oncology ,N-terminal telopeptide ,Internal medicine ,medicine ,Carcinoma ,Adenocarcinoma ,business ,Lung cancer ,human activities ,Survival rate - Abstract
The clinical significance of the serum crosslinked N-telopeptide of type I collagen (NTx) as a prognostic marker for non-small-cell lung cancer (NSCLC) was evaluated. We have revealed that a high serum NTx level (>22 nmol bone collagen equivalents (BCE)/L) appears to be a risk factor for a reduction in overall survival in patients with NSCLC. Introduction: Lung cancer is the leading cause of cancer-related death. Many patients with lung cancer are in its advanced stages at the time of diagnosis. The 5-year survival rate for lung cancer is 10% to 20%, and the prognosis for patients with lung cancer is still poor. The crosslinked N-terminal telopeptide of type I collagen (NTx) is a metabolite of type I collagen, the main constituent of bone matrix. Patients and Methods: We measured serum NTx levels in patients who underwent staging during hospitalization for the initial treatment of lung cancer in our department. We examined whether serum NTx levels would be relevant to the prognosis of non-small-cell lung cancer (NSCLC). Results: This study included 176 patients with lung cancer (125 men and 51 women), including 109 with adenocarcinoma, 53 with squamous cell carcinoma, 6 with large-cell carcinoma, and 8 with other cancer types. Univariate and multivariate analysis using the Cox proportional hazards model revealed a particularly close associ- ation between sex, performance status, disease stage, and serum NTx levels and overall survival (OS). A median OS of 368 days was observed for patients with a serum NTx level 22 nmol BCE/L, which was significantly longer than the 197 days for patients with a serum NTx level 22 nmol BCE/L (hazard ratio (HR), 2.02; 95% confidence interval (CI), 1.36-2.99; log-rank P.00037). Conclusions: We have revealed that a high serum NTx level ( 22 nmol BCE/L) appears to be a risk factor for a reduction in OS in patients with NSCLC.
- Published
- 2012
28. Usefulness of Serial Measurement of Serum N-Telopeptides of Type I Collogen (NTX) in Patients with Lung Cancer who Developed Bone Metastasis: A Prospective Study
- Author
-
M. Tamiya, S. Tokunaga, H. Okada, K. Taira, H. Daga, N. Morishita, H. Suzuki, N. Okamoto, K. Takeda, and T. Hirashima
- Subjects
Oncology ,Hematology - Published
- 2012
29. Pharmacokinetic properties of E3810, a new proton pump inhibitor, in healthy male volunteers
- Author
-
S, Yasuda, A, Ohnishi, T, Ogawa, Y, Tomono, J, Hasegawa, H, Nakai, Y, Shimamura, and N, Morishita
- Subjects
Adult ,Male ,Analysis of Variance ,Cross-Over Studies ,Dose-Response Relationship, Drug ,Administration, Oral ,Proton Pump Inhibitors ,Fasting ,Middle Aged ,2-Pyridinylmethylsulfinylbenzimidazoles ,Japan ,Food ,Rabeprazole ,Drug Evaluation ,Humans ,Benzimidazoles ,Chromatography, High Pressure Liquid ,Omeprazole ,Half-Life - Abstract
E3810 is a new H+,K(+)-ATPase inhibitor with a substituted benzimidazole, which is under clinical investigation for peptic ulcer treatment in Japan and the USA. Three separate studies were conducted to evaluate the safety and to establish the pharmacokinetic profile of E3810 after oral administration to healthy male subjects. E3810 was administered as: single oral doses (1, 3, 10, 20, 40 and 80 mg) in fasting conditions, a single oral dose (20 mg) after a meal and repeated oral doses (20 and 40 mg) once daily for 7 days. The concentrations of E3810 and its metabolites in plasma and urine were determined by HPLC methods with UV detection. E3810 was generally well tolerated by all subjects. In the single-dose study, Cmax and AUC increased with increasing doses in the dose range examined. The mean plasma half-life was about 1.0 hour and was dose-independent. The apparent oral clearance of E3810 ranged from 4.37 to 8.40 ml/min/kg. No significant deviation from linear pharmacokinetics was observed. Approximately, 30% of a dose was excreted into the urine as thioether carboxylic acid-E3810 and its glucuronide. The mean serum protein binding was 96.3%. No effect of food intake on the Cmax and AUC was observed while tmax after a meal was 1.7 hours longer than that in the fasting conditions. No appreciable change in drug pharmacokinetics was observed during repeated oral dosing of E3810.
- Published
- 1994
30. A randomized prospective study of gonadotrophin with or without gonadotrophin-releasing hormone agonist for treatment of unexplained infertility
- Author
-
N. Morishita, Y. Takaoka, Kenichi Tamate, Kazuo Sengoku, and Mutsuo Ishikawa
- Subjects
Infertility ,Adult ,Male ,endocrine system ,medicine.medical_specialty ,Menotropins ,medicine.drug_class ,medicine.medical_treatment ,Andrology ,Gonadotropin-Releasing Hormone ,Internal medicine ,Follicular phase ,medicine ,Humans ,Prospective Studies ,Unexplained infertility ,business.industry ,Artificial insemination ,Rehabilitation ,Obstetrics and Gynecology ,Infant ,medicine.disease ,Pregnancy rate ,Endocrinology ,Reproductive Medicine ,Ovulation induction ,Drug Therapy, Combination ,Female ,Gonadotropin ,business ,Infertility, Female - Abstract
The use of gonadotrophin-releasing hormone agonist (GnRHa) in combination with human menopausal gonadotrophin (HMG) for ovulation induction has been advocated for the treatment, particularly by in-vitro fertilization (IVF) of various types of infertility. The present study was designed to compare the clinical efficacy of HMG alone with a short protocol of GnRHa/HMG for treatment of unexplained infertility. A total of 91 couples with unexplained infertility were randomly assigned to one of two treatments; either HMG with intra-uterine insemination (IUI) (45 patients, 62 cycles) or GnRHa/HMG with IUI (46 patients, 69 cycles) treatments. Progesterone concentrations on the day of human chorionic gonadotrophin (HCG) administration were significantly higher in HMG (1.5 +/- 0.9 ng/ml) versus GnRHa/HMG (0.8 +/- 0.6 ng/ml; P < 0.05) cycles. Furthermore, GnRHa suppressed the occurrences of premature luteinization (GnRHa/HMG 5.8% and HMG 24.2% respectively). However, there were no significant differences in HMG dose requirements, plasma oestradiol concentrations or follicular development on the day of HCG administration between the two groups. Nor were any significant differences found in the pregnancy rates between the two treatment protocols (GnRHa/HMG 13.0% and HMG 11.3% respectively). Our results suggest no beneficial effect of GnRHa/HMG compared to HMG alone for the treatment of unexplained infertility, based on pregnancy rates.
- Published
- 1994
31. Stability of phase-change optical disks produced by a pass-through type sputtering system
- Author
-
M. Suzuki, N. Morishita, S. Tajima, M. Nakao, K. Nishimura, and M. Ohta
- Abstract
Many types of rewritable optical disks have been proposed and studied. Some of them are currently used for computer data storage and audio/video signal recording. Of these types, a phase-change rewritable (PCR) type shows great promise as a future optical recording media. It can be easily overwritten, and the carrier-to-noise ratio (CNR) is high over wide range of wavelengths, from 400nm to 900nm.1) A phase-change media shows high performance characteristics, but it has not been shown that a high performance phase-change media can be mass-produced, as MO media is.
- Published
- 1994
32. Pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy male volunteers
- Author
-
M, Mihara, A, Ohnishi, Y, Tomono, J, Hasegawa, Y, Shimamura, K, Yamazaki, and N, Morishita
- Subjects
Adult ,Male ,Blood Proteins ,Piperidines ,Alzheimer Disease ,Food ,Indans ,Humans ,Donepezil ,Single-Blind Method ,Spectrophotometry, Ultraviolet ,Cholinesterase Inhibitors ,Chromatography, High Pressure Liquid ,Protein Binding - Abstract
E2020 is a new cholinesterase inhibitor with a novel chemical structure, which is under clinical investigation for use in Alzheimer's disease in Japan and the USA. Three separate studies were conducted to evaluate the safety and to establish the pharmacokinetic profile of E2020 after oral administration to healthy male subjects. E2020 was administered as: (1) single oral doses (0.3 mg, 1 mg, 2 mg, 5 mg, 8 mg and 10 mg) in a fasting condition, (2) a single oral dose (2 mg) after a meal and (3) repeated oral doses (2 mg once daily for 21 days). The concentrations of E2020 and its metabolites in plasma, serum, urine and feces were determined by HPLC methods with UV detection. E2020 was generally well tolerated by all subjects. In the single-dose study, there was a linear relationship between dose and mean AUC. The mean plasma half-life was about 50 hours and was dose-independent. The total clearance and renal clearance of E2020 were also dose-independent and the mean values after 10 mg dosing were 9.7 l/hour and 0.86 l/hour, respectively. The cumulative total urinary and fecal excretion of the sum of unchanged E2020 and its metabolites at 264 hours after the administration of the single 10-mg-dose was 36.1% and 8.6% of the dose, respectively. The mean serum protein binding was 92.6%. No effect of food intake on the pharmacokinetics was observed. Evaluation of the mean trough levels and AUC0-24 of E2020 indicated that a steady-state was achieved after approximately 2 weeks of daily dosing.
- Published
- 1993
33. Development of Nickel Based Corrosion and Wear Resistant Alloy Manufactured by Reaction Sintering Hipping Process
- Author
-
N. Morishita, T. Nimade, H. Kawatani, A. Shimamoto, and N. Kawai
- Subjects
chemistry.chemical_classification ,Materials science ,Metallurgy ,Alloy ,Metals and Alloys ,Sintering ,Polymer ,Nickel based ,engineering.material ,Corrosion ,chemistry.chemical_compound ,chemistry ,Boride ,Phase (matter) ,engineering ,General Materials Science ,Injection moulding - Abstract
The development of a new alloy for the cylinders of injection moulding machines processing advanced reinforced polymers is described. Corrosion and wear tests produced a new composition that has comparable corrosion resistance to Hastelloy C together with wear resistance superior to currently used nickel based alloys containing a hard boride phase. The new alloy can be bonded to the interior of cylinders using a reaction sintering hipping route and has performed satisfactorily in service trials.
- Published
- 1991
34. Molecular Analysis of Malassezia Microflora from Patients with Pityriasis Versicolor.
- Author
-
N. Morishita, Y. Sei, and T. Sugita
- Subjects
METHYLENE blue ,THIAZINE dyes ,MICROORGANISMS ,CLINICAL trials - Abstract
Background: Pityriasis versicolor (PV) is a superficial infection of the stratum corneum caused by Malassezia species. Eleven species have been identified within this genus, namely M. globosa, M. restricta, M. sympodialis, M. furfur, M. obtusa, M. slooffiae, M. pachydermatis, M. dermatis, M. japonica, M. yamatoensis, M. nana. M. furfur has long been identified as the causative fungus of PV. However, recent studies using the culture and isolation identified by morphological and physiological characteristics suggest that M. globosa is the causative agent of PV. Objectives: The aim of this study was to examine the distribution of PV microorganisms with a molecular-based non-culture method. Patients: The subjects were 49 patients with PV (32 males, 17 females; 16–83 years old) who visited our outpatient clinic. Methods: Samples were taken from lesions for direct microscopy with methylene blue and detected Malassezia species without M. pachydermatis and M. nana using a non-culture-based method consisting of nested PCR with specific primers. Results: The most frequently isolated species were M. globosa and M. restricta (both 93.9%). Only M. globosa was detected from the lesion in which the mycelial form alone was observed microscopically, but M. restricta was not. Conclusions: Our results suggest that M. globosa is the causative agent of PV. [ABSTRACT FROM AUTHOR]
- Published
- 2006
35. Phase I Study of E1040, a New Parenteral Cephem Antibiotic
- Author
-
M. Nakashima, Mitsutaka Kanamaru, Y. Tomono, N. Morishita, Keiko Okano, K. Ueno, T. Setoyama, Toshihiko Uematsu, and Toshiro Ohno
- Subjects
Adult ,Male ,Pharmacology ,Cephem ,Nausea ,business.industry ,medicine.drug_class ,Urinary system ,Antibiotics ,Cmax ,Cephalosporins ,Feces ,Pharmacokinetics ,Anesthesia ,Toxicity ,medicine ,Drug Evaluation ,Humans ,Biological Assay ,Pharmacology (medical) ,medicine.symptom ,Infusions, Intravenous ,business ,Chromatography, High Pressure Liquid ,Antibacterial agent - Abstract
The safety and pharmacokinetics of E1040, a new injectable cephem antibiotic, were evaluated in healthy volunteers. In single-dose studies, 125, 250, 500, 1000 and 2000 mg of E1040 were administered by I.V. infusion over 1 hour. Results of 5 minutes I.V. infusions of 500, 1000 and 2000 mg of the drug were also studied. Plasma concentration-time profiles were well suited to a two-compartment open model. The half-life of elimination from plasma was 1.85 +/- 0.16 hours, and the Cmax and AUC paralleled the doses given. The mean urinary recovery within the first 24 hours was 85.7 +/- 6.43% of the dose. In a multiple-dose study, 2000 mg of E1040 (I.V. over 1 hour) was administered every 12 hours (total 9 times) and no abnormal accumulation of the drug in plasma was observed. There were no significant differences in plasma levels or in urinary recoveries between single- and multiple-dose regimens. There were no subjective or objective abnormal findings definitely attributable to the drug except that one subject given 250 mg over 1 hour reported diarrhea, and another complained of nausea during the infusion of 2000 mg over 5 minutes. From these results E1040 was concluded to be safe and well tolerated.
- Published
- 1989
36. [Studies on acid phosphatase in prostatic cancer. IV. Immunochemical assay of prostatic acid phosphatase (author's transl)]
- Author
-
N, Morishita
- Subjects
Male ,Counterimmunoelectrophoresis ,Acid Phosphatase ,Prostate ,Prostatic Hyperplasia ,Humans ,Prostatic Neoplasms ,Female - Published
- 1980
37. [Studies on acid phosphatase in prostatic cancer. III. Production of specific antibody against human prostatic acid phosphatase (author's transl)]
- Author
-
N, Morishita
- Subjects
Male ,Antibodies, Neoplasm ,Antibody Specificity ,Acid Phosphatase ,Prostate ,Humans ,Prostatic Neoplasms - Published
- 1980
38. The effect of assay methods on plasma levels and pharmacokinetics of theophylline: HPLC and EIA
- Author
-
M Watanabe, T Ishizaki, and N Morishita
- Subjects
Male ,Time Factors ,medicine.drug_class ,Microgram ,Pharmacology ,High-performance liquid chromatography ,Immunoenzyme Techniques ,Pharmacokinetics ,Theophylline ,Bronchodilator ,medicine ,Methods ,Humans ,Pharmacology (medical) ,Chromatography, High Pressure Liquid ,Chromatography ,Chemistry ,Half-life ,Assay sensitivity ,Standard curve ,Kinetics ,medicine.drug ,Half-Life ,Research Article - Abstract
1 The effects of two assay methods, HPLC and EIA, on theophylline plasma levels (n = 254) and pharmacokinetics (n = 6) were examined on blood samples obtained from asthmatic patients and normal adult male volunteers. 2 The standard curves obtained and the plasma level values during plasma level monitoring of theophylline measured with two methods are well correlated each other within concentration range of 2.5 to 20.0 microgram/ml (P less than 0.001). EIA, however in general, appears to give a lower value than HPLC. 3 The values of plasma theophylline half-life and clearance analyzed using a two-compartment open system model were found different between the two assay methods and dissimilar to those previously reported by using ultraviolet method. 4 The sampling end-point and/or assay sensitivity particularly to measure a lower level of theophylline (less than 2.5 microgram/ml) can influence the pharmacokinetics for a potent bronchodilator with a narrow therapeutic margin, theophylline.
- Published
- 1979
39. [Immunochemotherapy in prostatic cancer (author's transl)]
- Author
-
N, Morishita, Y, Minami, and K, Ihara
- Subjects
Male ,Picibanil ,Hexestrol ,Humans ,Prostatic Neoplasms ,Drug Therapy, Combination ,Adenocarcinoma ,Middle Aged ,Aged ,Mitomycins - Published
- 1981
40. [Management of active public health clinics--a force to withstand the trends for consolidation and closure of clinics]
- Author
-
N, Morishita, K, Oba, K, Kokubu, Y, Kajihara, and S, Oguri
- Subjects
Japan ,Public Health Nursing ,Humans ,Health Facilities ,Public Health ,Public Health Administration ,Health Facility Closure - Published
- 1986
41. [Studies on acid phosphatase in prostatic cancer. II. Investigation of acid phosphatase isoenzymes by ion-exchange column chromatography in serum and bone marrow of the patient with prostatic cancer (author's transl)]
- Author
-
N, Morishita
- Subjects
Isoenzymes ,Male ,Bone Marrow ,Acid Phosphatase ,Humans ,Prostatic Neoplasms ,Female ,Chromatography, Ion Exchange - Published
- 1980
42. [Studies on acid phosphatase in prostatic cancer. I. Acid phosphatase isoenzymes of various tissue extracts (author's transl)]
- Author
-
N, Morishita
- Subjects
Adult ,Isoenzymes ,Male ,Acid Phosphatase ,Humans ,Prostatic Neoplasms ,Electrophoresis, Polyacrylamide Gel ,Chromatography, Ion Exchange - Published
- 1980
43. [Studies on prophylaxis and therapy of pivmecillinam against post-prostatectomy urinary tract infection]
- Author
-
H, Kanetake, K, Shindo, Y, Kusaba, M, Kuniyoshi, Y, Yushita, N, Morishita, T, Sanefuji, J, Yamada, S, Ogawa, and F, Matsuya
- Subjects
Male ,Prostatectomy ,Postoperative Complications ,Premedication ,Urinary Tract Infections ,Prostatic Hyperplasia ,Humans ,Penicillanic Acid ,Amdinocillin Pivoxil ,Middle Aged ,Aged - Abstract
Patients received pivmecillinam (PMPC) after prophylactic use of various antimicrobial chemotherapeutic agents following prostatectomy, and their clinical responses were assessed for effectiveness in the treatment and prevention of postoperative infection. The data were also analyzed to explore the relationship between bacterial isolates obtained during the postoperative course and the antimicrobial agents administered prophylactically against postoperative infection. Therapeutic effect of PMPC: Treatment of postoperative infections with PMPC was effective in 36 (53.7%) out of 67 patients who had undergone prostatectomy. Prophylactic effect of PMPC: The use of PMPC provided effective prevention of infection in 22 (64.7%) out of 34 patients from whom no bacterial pathogen had been isolated before postoperative antimicrobial chemotherapy. Therapeutic responses to PMPC, compared between different types of operative procedure: There was little or no difference in therapeutic effectiveness of PMPC against postoperative infection when compared between two types of operative procedure, transurethral prostatectomy and subcapsular removal of the prostate. Incidence and types of bacterial isolates following prophylactic chemotherapy with various agents after prostatectomy: Possibly because cephapirin (CEPR) and ticarcillin (TIPC) were mainly administered, alone or in combination, for prophylaxis against postoperative infection, Serratia and Pseudomonas were most frequently isolated. The findings offer suggestions as to the appropriate combination of antimicrobial agents to be used for prophylactic purposes. Effectiveness of PMPC in the presence or absence of a preoperative indwelling urethral catheter: The use of PMPC was more effective both in the treatment and prevention of postoperative infection in cases without preoperative indwelling urethral catheterization than in those with it.
- Published
- 1984
44. Modification of immune response by cinnarizine
- Author
-
N. Morishita, T. Morimoto, and T. Ikeda
- Subjects
Lipopolysaccharides ,Cinnarizine ,Erythrocytes ,Lipopolysaccharide ,T-Lymphocytes ,Immunology ,chemical and pharmacologic phenomena ,Spleen ,Hemolytic Plaque Technique ,Pharmacology ,Toxicology ,Lymphocyte Activation ,Piperazines ,chemistry.chemical_compound ,Mice ,Immune system ,Suppressor T cell ,medicine ,Colchicine ,Animals ,Hypersensitivity, Delayed ,Lymphocytes ,B-Lymphocytes ,Mice, Inbred BALB C ,Sheep ,biology ,business.industry ,Kinetics ,medicine.anatomical_structure ,Immunization ,chemistry ,Polyclonal antibodies ,Mice, Inbred DBA ,Antibody Formation ,biology.protein ,Female ,business ,medicine.drug - Abstract
Effects of cinnarizine on immune response in mice were investigated. Mice were orally administered with cinnarizine and were immunized with sheep red blood cells (SRBC) intravenously. Numbers of plaque forming cells (PFC) to SRBC in spleen of these mice were assayed and delayed-type hypersensitivity (DTH) response to SRBC was measured. 1) PFC response in immunization with 5 X 10(6) cells/mouse of SRBC was enhanced by administration of 25 mg/kg of cinnarizine, while the response in immunization with 5 X 10(8) cells/mouse was suppressed by 25 to 200 mg/kg of cinnarizine. 2) From study on timing of administration, suppression of PFC response by 6.25 to 200 mg/kg of cinnarizine was observed at 24 hr. after the immunization. 3) 12.5 to 200 mg/kg of cinnarizine suppressed polyclonal B cell activation induced by lipopolysaccharide (LPS). 4) Colchicine induced suppressor T cell inactivation was prevented by administration of 50 mg/kg of cinnarizine and it was suggested that cinnarizine may induce suppressor T cells from the study of adoptive cell transfer system. 5) 50 mg/kg of cinnarizine showed the suppression of DTH response in expression phase, but not in induction phase. It was concluded that immune responses in mice were modified by cinnarizine.
- Published
- 1982
45. Pharmacokinetic study of deuterium-labelled coenzyme Q10 in man
- Author
-
Y, Tomono, J, Hasegawa, T, Seki, K, Motegi, and N, Morishita
- Subjects
Adult ,Male ,Kinetics ,Ubiquinone ,Coenzymes ,Administration, Oral ,Biological Availability ,Humans ,Middle Aged ,Deuterium - Abstract
The pharmacokinetics of coenzyme Q10 (CoQ10) in man was studied by utilizing deuterium-labelled coenzyme Q10 (d5-CoQ10). The absence of an isotope effect in the disposition of d5-CoQ10 in man was confirmed from the plasma concentration time curves after simultaneous oral dosing of d5-CoQ10 and unlabelled CoQ10. After oral administration of 100 mg of d5-CoQ10 to 16 healthy male subjects, the mean plasma CoQ10 level attained a peak of 1.004 +/- 0.370 micrograms/ml at 6.5 +/- 1.5 h after administration, and the terminal elimination half-life was 33.19 +/- 5.32 h. In most of the subjects, plasma d5-CoQ10 showed a second peak at 24 h after dosing. This unusual plasma level curve was well described by a newly proposed compartment model based upon the assumption that absorbed CoQ10 is taken up by the liver and then transferred mainly to VLDL and redistributed from the liver to the systemic blood.
- Published
- 1986
46. [Studies on benzoheterocyclic compounds. V. Synthesis of benzoxazolinone and benzoxazinone derivatives. 3]
- Author
-
S, Toyoshima and N, Morishita
- Subjects
Benzoxazoles ,Sulfonamides ,Oxazines ,Polycyclic Compounds - Published
- 1966
47. [Studies on the benzoheterocyclic compounds. 3. Synthesis of benzoxazinone derivatives. I]
- Author
-
S, Toyoshima and N, Morishita
- Subjects
Central Nervous System ,Benzoxazoles ,Oxazines ,Polycyclic Compounds ,In Vitro Techniques - Published
- 1966
48. Satellite-based navigation/air traffic control systems for short range aircraft
- Author
-
M. Abzug, N. Morishita, and J. Craigie
- Subjects
Wide area multilateration ,Automatic dependent surveillance-broadcast ,business.industry ,Range (aeronautics) ,Aircraft vectoring ,Real-time computing ,Performance-based navigation ,Wind triangle ,Environmental science ,Satellite ,Air traffic control ,Aerospace engineering ,business - Published
- 1970
49. [Case of hemiplegia associated with habitual dislocation of the temporo mandibular joint]
- Author
-
M, Onishi, K, Ishibashi, N, Morishita, M, Shimizu, and T, Ueno
- Subjects
Temporomandibular Joint ,Joint Dislocations ,Humans ,Hemiplegia ,Middle Aged - Published
- 1973
50. Population pharmacokinetics of an antiarrhythmic, lidocaine, analyzed by NONMEM and the effect of sample size on the analysis
- Author
-
M. Nakashima, N. Morishita, Y. Tomono, Toshihiko Uematsu, and Hiroyuki Matsuno
- Subjects
Pharmacology ,Lidocaine ,business.industry ,Sample size determination ,Anesthesia ,Medicine ,Population pharmacokinetics ,business ,medicine.drug ,NONMEM - Published
- 1989
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.